GnRH agonist trigger in poor prognosis patients undergoing a multicycle approach through DuoStim or consecutive stimulations: a SWOT analysis

Curr Opin Obstet Gynecol. 2024 Jun 1;36(3):124-133. doi: 10.1097/GCO.0000000000000947. Epub 2024 Mar 26.

Abstract

Purpose of review: Identify the most recent and significant evidence regarding the ovulation trigger within the framework of a multicycle approach through DuoStim, providing valuable insights for improving treatment strategies in patients with a poor prognosis.

Recent findings: The trigger method plays a pivotal role in optimizing in-vitro fertilization (IVF) stimulation, influencing oocyte retrieval and maturation rates, as well as follicle recruitment in consecutive ovarian stimulations such as double stimulation. Decision-making involves multiple factors and, while guidelines exist for conventional stimulation, specific recommendations for the multicycle approach are not well established.

Summary: The different methods for inducing oocyte maturation underscore the need for personalization of IVF protocols. The GnRH agonist trigger induces rapid luteolysis and establishes favorable hormonal conditions that do not adversely affect the recruitment of consecutive follicular waves in the context of DuoStim. It serves as a valid alternative to hCG in freeze-all cycles. This strategy might enhance the safety and flexibility of ovarian stimulations with no impact on oocyte competence and IVF efficacy.

Publication types

  • Review

MeSH terms

  • Chorionic Gonadotropin / therapeutic use
  • Female
  • Fertility Agents, Female / therapeutic use
  • Fertilization in Vitro* / methods
  • Gonadotropin-Releasing Hormone* / agonists
  • Humans
  • Oocyte Retrieval* / methods
  • Ovulation Induction* / methods
  • Pregnancy
  • Pregnancy Rate
  • Prognosis
  • Triptorelin Pamoate / therapeutic use

Substances

  • Gonadotropin-Releasing Hormone
  • Fertility Agents, Female
  • Triptorelin Pamoate
  • Chorionic Gonadotropin